| Application no. and date | 18704122.3 (espacenet) (Federated) (European Patent Register), 20180123 | | Patent/reg. no. and date | DK/EP 3571193, 20211201 | | Publication date | 20191127 | | Priority no. and date | US 201762449270 P, 20170123 | | EP pub. no. and date |
EP 3571193 20191127 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | | | Inventor | JACOBSEN, Thomas, Amos, Vaenget 1, 3310 Ølsted, DK,
JEFSON, Martin, R., 106 Water Street
Stonington
CT 06378, US,
LARSEN, Janus, Schreiber, Fasanvej 29, 4300 Holbæk, DK,
KEANEY, Gregg, F., 34 Robbins Road
Lexington
MA 02421, US,
AMRUTKAR, Dipak, Vasantrao, Baltorpvej 154, 2750 Ballerup, DK,
FOSTER, Kelly, 232 Common Street
Watertown
MA 02139, US,
NIELSEN, Karin, Sandager, Vilhelmsro 411, 3480 Fredensborg, DK | | Representative | | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61P 25/30 (2006.01) , C07D 403/04 (2006.01) , C07D 417/04 (2006.01) | | Title | Potassium Channel Modulators | | Int. application no. | US2018014792 | | Int. publication no. | WO2018136917 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
